Inside the Bradfield Centre / Episode 42 - Jenny Barnett, CEO, Monument Therapeutics

Listen on

Episode notes

James chats to Jennifer Barnett, CEO at Monument Therapeutics, a Cambridge Angels portfolio company. We cover Jennifer's career path, the experience of spinning out from Cambridge Cognition, the problem Monument Therapeutics solves, managing a dispersed team, and their plans for the future.